首页 > 最新文献

Biostatistics and Epidemiology最新文献

英文 中文
Classification accuracy goals for diagnostic tests based on risk stratification 基于风险分层的诊断测试分类准确性目标
Q3 Medicine Pub Date : 2021-03-17 DOI: 10.1080/24709360.2021.1878406
G. Pennello
In diagnostic test evaluation, performance goals are often set for classification accuracy measures such as specificity, sensitivity and diagnostic likelihood ratio. For tests that detect rare conditions, classification accuracy goals are attractive because they can be evaluated in case-control studies enriched for the condition. A neglected area of research is determining classification accuracy goals that confer clinical usefulness of a test. We determine classification accuracy goals based on desired risk stratification, i.e. the post-test risk of having the condition compared with the pre-test risk. We determine goals for rule-out tests, rule-in tests, and those that do both. Goals for negative and positive likelihood ratios (NLR, PLR) are emphasized because of their natural relationships with risk stratification via Bayes Theorem. Goals for specificity and sensitivity are implied by goals on NLR and PLR. Goals that confer superiority or non-inferiority of a test to a comparator are based on approximating risk differences and relative risks by functions of likelihood ratios. Inference is based on Wald confidence intervals for ratios of likelihood ratios. To illustrate, we consider hypothetical data on a fetal fibronectin assay for ruling out risk of pre-term birth and two human papillomavirus assays for detecting cervical cancer. Trial registration ClinicalTrials.gov identifier: NCT01931566.
在诊断测试评估中,通常为分类准确性指标设定性能目标,如特异性、敏感性和诊断似然比。对于检测罕见疾病的测试,分类准确性目标很有吸引力,因为它们可以在针对该疾病的病例对照研究中进行评估。一个被忽视的研究领域是确定分类准确性目标,从而赋予测试临床实用性。我们根据期望的风险分层来确定分类准确性目标,即与测试前风险相比,测试后出现这种情况的风险。我们确定排除测试、规则引入测试以及两者兼而有之的测试的目标。负似然比和正似然比(NLR,PLR)的目标被强调,因为它们通过贝叶斯定理与风险分层有着天然的关系。NLR和PLR的目标隐含了特异性和敏感性的目标。将测试的优缺点赋予比较者的目标是基于通过似然比函数近似风险差异和相对风险。推理是基于似然比的Wald置信区间。为了说明这一点,我们考虑了一项用于排除早产风险的胎儿纤连蛋白检测和两项用于检测宫颈癌症的人乳头瘤病毒检测的假设数据。试验注册ClinicalTrials.gov标识符:NCT01931566。
{"title":"Classification accuracy goals for diagnostic tests based on risk stratification","authors":"G. Pennello","doi":"10.1080/24709360.2021.1878406","DOIUrl":"https://doi.org/10.1080/24709360.2021.1878406","url":null,"abstract":"In diagnostic test evaluation, performance goals are often set for classification accuracy measures such as specificity, sensitivity and diagnostic likelihood ratio. For tests that detect rare conditions, classification accuracy goals are attractive because they can be evaluated in case-control studies enriched for the condition. A neglected area of research is determining classification accuracy goals that confer clinical usefulness of a test. We determine classification accuracy goals based on desired risk stratification, i.e. the post-test risk of having the condition compared with the pre-test risk. We determine goals for rule-out tests, rule-in tests, and those that do both. Goals for negative and positive likelihood ratios (NLR, PLR) are emphasized because of their natural relationships with risk stratification via Bayes Theorem. Goals for specificity and sensitivity are implied by goals on NLR and PLR. Goals that confer superiority or non-inferiority of a test to a comparator are based on approximating risk differences and relative risks by functions of likelihood ratios. Inference is based on Wald confidence intervals for ratios of likelihood ratios. To illustrate, we consider hypothetical data on a fetal fibronectin assay for ruling out risk of pre-term birth and two human papillomavirus assays for detecting cervical cancer. Trial registration ClinicalTrials.gov identifier: NCT01931566.","PeriodicalId":37240,"journal":{"name":"Biostatistics and Epidemiology","volume":"5 1","pages":"149 - 168"},"PeriodicalIF":0.0,"publicationDate":"2021-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/24709360.2021.1878406","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44791322","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High-dimensional inference for the average treatment effect under model misspecification using penalized bias-reduced double-robust estimation 利用惩罚偏倚减少的双鲁棒估计对模型错误规范下的平均处理效果进行高维推断
Q3 Medicine Pub Date : 2021-03-17 DOI: 10.1080/24709360.2021.1898730
Vahe Avagyan, S. Vansteelandt
The presence of confounding by high-dimensional variables complicates the estimation of the average effect of a point treatment. On the one hand, it necessitates the use of variable selection strategies or more general high-dimensional statistical methods. On the other hand, the use of such techniques tends to result in biased estimators with a non-standard asymptotic behavior. Double-robust estimators are useful for offering a resolution because they possess a so-called small bias property. This property has been exploited to achieve valid (uniform) inference of the average causal effect when data-adaptive estimators of the propensity score and conditional outcome mean both converge to their respective truths at sufficiently fast rate. In this article, we extend this work in order to retain valid (uniform) inference when one of these estimators does not converge to the truth, regardless of which. This is done by generalizing prior work for low-dimensional settings by [Vermeulen K, Vansteelandt S. Bias-reduced doubly robust estimation. Am Stat Assoc. 2015;110(511):1024–1036.] to incorporate regularization. The proposed penalized bias-reduced double-robust estimation strategy exhibits promising performance in simulation studies and a data analysis, relative to competing proposals.
高维变量混杂的存在使积分治疗的平均效果的估计变得复杂。一方面,它需要使用变量选择策略或更通用的高维统计方法。另一方面,使用这种技术往往会导致具有非标准渐近行为的有偏估计量。双稳健估计量对于提供分辨率是有用的,因为它们具有所谓的小偏差性质。当倾向得分和条件结果均值的数据自适应估计量都以足够快的速度收敛到它们各自的真理时,这一特性已被用来实现平均因果效应的有效(一致)推断。在本文中,我们扩展了这项工作,以便在其中一个估计量不收敛于真值时保持有效(一致)推断,无论是哪一个。这是通过将[Vermeulen K,Vansteelandt S.Bias reduced double robust estimation.Am Stat Assoc.2015;110(511):1024–1036.]对低维设置的先前工作进行推广来实现的。相对于竞争方案,所提出的惩罚偏差减少双稳健估计策略在模拟研究和数据分析中表现出了良好的性能。
{"title":"High-dimensional inference for the average treatment effect under model misspecification using penalized bias-reduced double-robust estimation","authors":"Vahe Avagyan, S. Vansteelandt","doi":"10.1080/24709360.2021.1898730","DOIUrl":"https://doi.org/10.1080/24709360.2021.1898730","url":null,"abstract":"The presence of confounding by high-dimensional variables complicates the estimation of the average effect of a point treatment. On the one hand, it necessitates the use of variable selection strategies or more general high-dimensional statistical methods. On the other hand, the use of such techniques tends to result in biased estimators with a non-standard asymptotic behavior. Double-robust estimators are useful for offering a resolution because they possess a so-called small bias property. This property has been exploited to achieve valid (uniform) inference of the average causal effect when data-adaptive estimators of the propensity score and conditional outcome mean both converge to their respective truths at sufficiently fast rate. In this article, we extend this work in order to retain valid (uniform) inference when one of these estimators does not converge to the truth, regardless of which. This is done by generalizing prior work for low-dimensional settings by [Vermeulen K, Vansteelandt S. Bias-reduced doubly robust estimation. Am Stat Assoc. 2015;110(511):1024–1036.] to incorporate regularization. The proposed penalized bias-reduced double-robust estimation strategy exhibits promising performance in simulation studies and a data analysis, relative to competing proposals.","PeriodicalId":37240,"journal":{"name":"Biostatistics and Epidemiology","volume":"6 1","pages":"221 - 238"},"PeriodicalIF":0.0,"publicationDate":"2021-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/24709360.2021.1898730","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48653333","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 12
Case fatality risk estimated from routinely collected disease surveillance data: application to COVID–19 根据常规收集的疾病监测数据估计的病死率风险:在COVID-19中的应用
Q3 Medicine Pub Date : 2021-01-02 DOI: 10.1080/24709360.2021.1913708
I. Marschner
Case fatality risk (CFR) is the probability of death among cases of a disease. A crude CFR estimate is the ratio of the number deaths to the number of cases of the disease. This estimate is biased, however, particularly during outbreaks of emerging infectious diseases such as COVID-19, because the death time of recent cases is subject to right censoring. Instead, we propose deconvolution methods applied to routinely collected surveillance data of unlinked case and death counts over time. We begin by considering the death series to be the convolution of the case series and the fatality distribution, which is the subdistribution of the time between diagnosis and death. We then use deconvolution methods to estimate this fatality distribution. This provides a CFR estimate together with information about the distribution of time to death. Importantly, this information is extracted without the need to make strong assumptions used in previous analyses. The methods are applied to COVID-19 surveillance data from a range of countries illustrating substantial CFR differences. Simulations show that crude approaches lead to underestimation, particularly early in an outbreak, and that the proposed approach can rectify this bias. An R package called covidSurv is available for implementing the analyses.
病死率风险(CFR)是指疾病病例中死亡的概率。粗略估计的病死率是指死亡人数与患病人数之比。然而,这一估计有偏差,特别是在COVID-19等新出现的传染病爆发期间,因为最近病例的死亡时间需要进行正确的审查。相反,我们建议将反卷积方法应用于常规收集的随时间变化的无关联病例和死亡计数的监测数据。我们首先考虑死亡序列是病例序列和病死率分布的卷积,病死率分布是诊断和死亡之间时间的子分布。然后,我们使用反卷积方法来估计这种死亡率分布。这提供了病死率估计值以及有关死亡时间分布的信息。重要的是,提取这些信息时不需要像以前的分析那样做出强有力的假设。这些方法应用于来自一系列国家的COVID-19监测数据,这些数据显示病死率存在巨大差异。模拟表明,粗糙的方法会导致低估,特别是在爆发初期,而提出的方法可以纠正这种偏差。一个名为covid - surv的R包可用于实施分析。
{"title":"Case fatality risk estimated from routinely collected disease surveillance data: application to COVID–19","authors":"I. Marschner","doi":"10.1080/24709360.2021.1913708","DOIUrl":"https://doi.org/10.1080/24709360.2021.1913708","url":null,"abstract":"Case fatality risk (CFR) is the probability of death among cases of a disease. A crude CFR estimate is the ratio of the number deaths to the number of cases of the disease. This estimate is biased, however, particularly during outbreaks of emerging infectious diseases such as COVID-19, because the death time of recent cases is subject to right censoring. Instead, we propose deconvolution methods applied to routinely collected surveillance data of unlinked case and death counts over time. We begin by considering the death series to be the convolution of the case series and the fatality distribution, which is the subdistribution of the time between diagnosis and death. We then use deconvolution methods to estimate this fatality distribution. This provides a CFR estimate together with information about the distribution of time to death. Importantly, this information is extracted without the need to make strong assumptions used in previous analyses. The methods are applied to COVID-19 surveillance data from a range of countries illustrating substantial CFR differences. Simulations show that crude approaches lead to underestimation, particularly early in an outbreak, and that the proposed approach can rectify this bias. An R package called covidSurv is available for implementing the analyses.","PeriodicalId":37240,"journal":{"name":"Biostatistics and Epidemiology","volume":"5 1","pages":"49 - 68"},"PeriodicalIF":0.0,"publicationDate":"2021-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/24709360.2021.1913708","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"60127878","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Methods for detecting outlying regions and influence diagnosis in multi-regional clinical trials 多区域临床试验中边缘区域的检测方法及影响诊断
Q3 Medicine Pub Date : 2021-01-02 DOI: 10.1080/24709360.2021.1921944
M. Aoki, H. Noma, M. Gosho
Due to the globalization of drug development, multi-regional clinical trials (MRCTs) have been increasingly adopted in clinical evaluations. In MRCTs, the primary objective is to demonstrate the efficacy of new drugs in all participating regions, but heterogeneity of various relevant factors across these regions can cause inconsistency of treatment effects. In particular, outlying regions with extreme profiles can influence the overall conclusions of these studies. In this article, we propose quantitative methods to detect these outlying regions and to assess their influences in MRCTs. The approaches are as follows: (1) a method using a dfbeta-like measure, a studentized residual obtained by a leave-one-out cross-validation (LOOCV) scheme; (2) a model-based significance testing method using a mean-shifted model; (3) a method using a relative change measure for the variance estimate of the overall effect estimator; and (4) a method using a relative change measure for the heterogeneity variance estimate in a random-effects model. Parametric bootstrap schemes are proposed to accurately assess the statistical significance and variabilities of the aforementioned influence diagnostic tools. We illustrate the effectiveness of these proposed methods via applications to two MRCTs, the RECORD and RENAAL studies.
由于药物开发的全球化,多区域临床试验(MRCT)越来越多地被用于临床评估。在MRCT中,主要目标是证明新药在所有参与区域的疗效,但这些区域的各种相关因素的异质性可能导致治疗效果的不一致。特别是,具有极端剖面的边远地区可能会影响这些研究的总体结论。在这篇文章中,我们提出了定量方法来检测这些边缘区域,并评估它们在MRCT中的影响。方法如下:(1)使用类dfbeta测度的方法,即通过留一交叉验证(LOOCV)方案获得的学生化残差;(2) 使用均值偏移模型的基于模型的显著性测试方法;(3) 将相对变化度量用于所述总体效应估计器的方差估计的方法;以及(4)一种在随机效应模型中使用相对变化度量来估计异质性方差的方法。提出了参数自举方案,以准确评估上述影响诊断工具的统计显著性和可变性。我们通过应用于两项MRCT,即RECORD和RENAL研究来说明这些拟议方法的有效性。
{"title":"Methods for detecting outlying regions and influence diagnosis in multi-regional clinical trials","authors":"M. Aoki, H. Noma, M. Gosho","doi":"10.1080/24709360.2021.1921944","DOIUrl":"https://doi.org/10.1080/24709360.2021.1921944","url":null,"abstract":"Due to the globalization of drug development, multi-regional clinical trials (MRCTs) have been increasingly adopted in clinical evaluations. In MRCTs, the primary objective is to demonstrate the efficacy of new drugs in all participating regions, but heterogeneity of various relevant factors across these regions can cause inconsistency of treatment effects. In particular, outlying regions with extreme profiles can influence the overall conclusions of these studies. In this article, we propose quantitative methods to detect these outlying regions and to assess their influences in MRCTs. The approaches are as follows: (1) a method using a dfbeta-like measure, a studentized residual obtained by a leave-one-out cross-validation (LOOCV) scheme; (2) a model-based significance testing method using a mean-shifted model; (3) a method using a relative change measure for the variance estimate of the overall effect estimator; and (4) a method using a relative change measure for the heterogeneity variance estimate in a random-effects model. Parametric bootstrap schemes are proposed to accurately assess the statistical significance and variabilities of the aforementioned influence diagnostic tools. We illustrate the effectiveness of these proposed methods via applications to two MRCTs, the RECORD and RENAAL studies.","PeriodicalId":37240,"journal":{"name":"Biostatistics and Epidemiology","volume":"5 1","pages":"30 - 48"},"PeriodicalIF":0.0,"publicationDate":"2021-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/24709360.2021.1921944","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45719376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Region as a risk factor for asthma prevalence: statistical evidence from administrative data 地区作为哮喘患病率的危险因素:来自行政数据的统计证据
Q3 Medicine Pub Date : 2021-01-02 DOI: 10.1080/24709360.2021.1924495
R. Wesonga, Khidir M. Abdelbasit
Geographical regions may have an influence on asthma exacerbation. No conclusive study has been conducted to fully support or dissipate this assertion. We sought to use a data-driven approach to investigate the possible effect of geographical location on asthma. This study was based on data collected by the Ministry of Health over a 6-year period from 2010 to 2015 and presented in their annual reports. Prevalence rates for 11 regions were computed using the analysis of variance and regression models to determine the proximal nature of the region as a risk factor for asthma. Our results show a statistically significant difference in prevalence rates of asthma among the 11 regions. The asthma prevalence rate among the male population was 18% (OR = 1.18, p = .011) more than for the female population. There was a positive marginal increase in the asthma prevalence over the period. Further, five groups were derived based on asthma prevalence rates and trends. The region has proximal risk factor and significantly associated with asthma prevalence over the period. We recommend the creation of a control mechanism that targets regions with higher prevalence and increasing trends.
地理区域可能对哮喘恶化有影响。没有进行任何结论性研究来完全支持或消除这一说法。我们试图使用数据驱动的方法来研究地理位置对哮喘的可能影响。这项研究基于卫生部在2010年至2015年6年期间收集的数据,并在其年度报告中提出。使用方差分析和回归模型计算了11个地区的患病率,以确定该地区作为哮喘风险因素的近端性质。我们的研究结果显示,11个地区的哮喘患病率存在统计学上的显著差异。男性人群哮喘患病率为18%(OR = 1.18,p = .011)比女性人口多。在这段时间内,哮喘患病率有一个正的边际增长。此外,根据哮喘患病率和趋势得出了五组。该地区具有近端风险因素,并与该时期的哮喘患病率显著相关。我们建议建立一个控制机制,针对流行率较高和呈上升趋势的地区。
{"title":"Region as a risk factor for asthma prevalence: statistical evidence from administrative data","authors":"R. Wesonga, Khidir M. Abdelbasit","doi":"10.1080/24709360.2021.1924495","DOIUrl":"https://doi.org/10.1080/24709360.2021.1924495","url":null,"abstract":"Geographical regions may have an influence on asthma exacerbation. No conclusive study has been conducted to fully support or dissipate this assertion. We sought to use a data-driven approach to investigate the possible effect of geographical location on asthma. This study was based on data collected by the Ministry of Health over a 6-year period from 2010 to 2015 and presented in their annual reports. Prevalence rates for 11 regions were computed using the analysis of variance and regression models to determine the proximal nature of the region as a risk factor for asthma. Our results show a statistically significant difference in prevalence rates of asthma among the 11 regions. The asthma prevalence rate among the male population was 18% (OR = 1.18, p = .011) more than for the female population. There was a positive marginal increase in the asthma prevalence over the period. Further, five groups were derived based on asthma prevalence rates and trends. The region has proximal risk factor and significantly associated with asthma prevalence over the period. We recommend the creation of a control mechanism that targets regions with higher prevalence and increasing trends.","PeriodicalId":37240,"journal":{"name":"Biostatistics and Epidemiology","volume":"5 1","pages":"19 - 29"},"PeriodicalIF":0.0,"publicationDate":"2021-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/24709360.2021.1924495","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42433147","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative analysis of epidemiological models for COVID-19 pandemic predictions COVID-19大流行预测流行病学模型的比较分析
Q3 Medicine Pub Date : 2021-01-02 DOI: 10.1080/24709360.2021.1913709
Rajan Gupta, G. Pandey, S. Pal
Epidemiological modeling is an important problem around the world. This research presents COVID-19 analysis to understand which model works better for different regions. A comparative analysis of three growth curve fitting models (Gompertz, Logistic, and Exponential), two mathematical models (SEIR and IDEA), two forecasting models (Holt's exponential and ARIMA), and four machine/deep learning models (Neural Network, LSTM Networks, GANs, and Random Forest) using three evaluation criteria on ten prominent regions around the world from North America, South America, Europe, and Asia has been presented. The minimum and median values for RMSE were 1.8 and 5372.9; the values for the mean absolute percentage error were 0.005 and 6.63; and the values for AIC were 87.07 and 613.3, respectively, from a total of 125 experiments across 10 regions. The growth curve fitting models worked well where flattening of the cases has started. Based on region's growth curve, a relevant model from the list can be used for predicting the number of infected cases for COVID-19. Some other models used in forecasting the number of cases have been added in the future work section, which can help researchers to forecast the number of cases in different regions of the world.
流行病学建模是世界范围内的一个重要问题。本研究提出了COVID-19分析,以了解哪种模式更适合不同地区。在北美、南美、欧洲和亚洲的10个主要地区,采用3种评价标准,对3种增长曲线拟合模型(Gompertz、Logistic和Exponential)、2种数学模型(SEIR和IDEA)、2种预测模型(Holt’s Exponential和ARIMA)和4种机器/深度学习模型(Neural Network、LSTM Networks、gan和Random Forest)进行了比较分析。RMSE的最小值和中位数分别为1.8和5372.9;平均绝对百分比误差分别为0.005和6.63;10个地区共125个试验的AIC值分别为87.07和613.3。增长曲线拟合模型在情况开始趋于平缓的地方效果很好。根据区域增长曲线,利用列表中的相关模型预测新冠肺炎感染病例数。在未来工作部分增加了一些用于预测病例数的其他模型,可以帮助研究人员预测世界不同地区的病例数。
{"title":"Comparative analysis of epidemiological models for COVID-19 pandemic predictions","authors":"Rajan Gupta, G. Pandey, S. Pal","doi":"10.1080/24709360.2021.1913709","DOIUrl":"https://doi.org/10.1080/24709360.2021.1913709","url":null,"abstract":"Epidemiological modeling is an important problem around the world. This research presents COVID-19 analysis to understand which model works better for different regions. A comparative analysis of three growth curve fitting models (Gompertz, Logistic, and Exponential), two mathematical models (SEIR and IDEA), two forecasting models (Holt's exponential and ARIMA), and four machine/deep learning models (Neural Network, LSTM Networks, GANs, and Random Forest) using three evaluation criteria on ten prominent regions around the world from North America, South America, Europe, and Asia has been presented. The minimum and median values for RMSE were 1.8 and 5372.9; the values for the mean absolute percentage error were 0.005 and 6.63; and the values for AIC were 87.07 and 613.3, respectively, from a total of 125 experiments across 10 regions. The growth curve fitting models worked well where flattening of the cases has started. Based on region's growth curve, a relevant model from the list can be used for predicting the number of infected cases for COVID-19. Some other models used in forecasting the number of cases have been added in the future work section, which can help researchers to forecast the number of cases in different regions of the world.","PeriodicalId":37240,"journal":{"name":"Biostatistics and Epidemiology","volume":"5 1","pages":"69 - 91"},"PeriodicalIF":0.0,"publicationDate":"2021-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/24709360.2021.1913709","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48622498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Estimating the AUC with a Graphical Lasso Method for High-dimensional Biomarkers with LOD. 用带LOD的高维生物标志物的图形套索法估计AUC
Q3 Medicine Pub Date : 2021-01-01 Epub Date: 2021-03-17 DOI: 10.1080/24709360.2021.1898731
Jirui Wang, Yunpeng Zhao, Liansheng Larry Tang

This manuscript estimates the area under the receiver operating characteristic curve (AUC) of combined biomarkers in a high-dimensional setting. We propose a penalization approach to the inference of precision matrices in the presence of the limit of detection. A new version of expectation-maximization algorithm is then proposed for the penalized likelihood, with the use of numerical integration and the graphical lasso method. The estimated precision matrix is then applied to the inference of AUCs. The proposed method outperforms the existing methods in numerical studies. We apply the proposed method to a data set of brain tumor study. The results show a higher accuracy on the estimation of AUC compared with the existing methods.

本文估计了在高维环境中组合生物标志物的接收器工作特征曲线(AUC)下的面积。在存在检测极限的情况下,我们提出了一种精度矩阵推理的惩罚方法。利用数值积分法和图形套索法,提出了一种新的惩罚似然期望最大化算法。然后将估计的精度矩阵应用于auc的推理。该方法在数值研究中优于现有方法。我们将所提出的方法应用于脑肿瘤研究数据集。结果表明,与现有方法相比,该方法对AUC的估计具有更高的精度。
{"title":"Estimating the AUC with a Graphical Lasso Method for High-dimensional Biomarkers with LOD.","authors":"Jirui Wang, Yunpeng Zhao, Liansheng Larry Tang","doi":"10.1080/24709360.2021.1898731","DOIUrl":"10.1080/24709360.2021.1898731","url":null,"abstract":"<p><p>This manuscript estimates the area under the receiver operating characteristic curve (AUC) of combined biomarkers in a high-dimensional setting. We propose a penalization approach to the inference of precision matrices in the presence of the limit of detection. A new version of expectation-maximization algorithm is then proposed for the penalized likelihood, with the use of numerical integration and the graphical lasso method. The estimated precision matrix is then applied to the inference of AUCs. The proposed method outperforms the existing methods in numerical studies. We apply the proposed method to a data set of brain tumor study. The results show a higher accuracy on the estimation of AUC compared with the existing methods.</p>","PeriodicalId":37240,"journal":{"name":"Biostatistics and Epidemiology","volume":"5 1","pages":"189-206"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9000202/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44107211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A note on modeling placement values in the analysis of receiver operating characteristic curves. 对接收机工作特性曲线分析中建模放置值的说明。
Q3 Medicine Pub Date : 2021-01-01 Epub Date: 2020-03-22 DOI: 10.1080/24709360.2020.1737794
Zhen Chen, Soutik Ghosal

Recent advances in receiver operating characteristic (ROC) curve analyses advocate modeling of placement value (PV), a quantity that measures the position of diseased test scores relative to the healthy population. Compared to traditional approaches, this PV-based alternative works directly with ROC curves and is attractive when assessing covariate effects on, or incorporating a priori constraints of, ROC curves. Several distributions can be used to model the PV, yet little guidelines exist in the literature on which to use. Through extensive simulation studies, we investigate several parametric models for PV when data are generated from a variety of mechanisms. We discuss the pros and cons of each of these models and illustrate their applications with data from a study of prenatal ultrasound examinations and large-for-gestational age birth.

接受者工作特征(ROC)曲线分析的最新进展提倡放置值(PV)建模,PV是一个测量患病测试分数相对于健康人群的位置的数量。与传统方法相比,这种基于pv的替代方法直接适用于ROC曲线,并且在评估ROC曲线的协变量效应或纳入ROC曲线的先验约束时具有吸引力。可以使用几种分布来对PV进行建模,但是在文献中很少有使用这些分布的指导方针。通过广泛的模拟研究,我们研究了从各种机制产生数据时PV的几个参数模型。我们讨论了这些模型的优点和缺点,并从产前超声检查和大胎龄出生的研究数据说明了它们的应用。
{"title":"A note on modeling placement values in the analysis of receiver operating characteristic curves.","authors":"Zhen Chen, Soutik Ghosal","doi":"10.1080/24709360.2020.1737794","DOIUrl":"10.1080/24709360.2020.1737794","url":null,"abstract":"<p><p>Recent advances in receiver operating characteristic (ROC) curve analyses advocate modeling of placement value (PV), a quantity that measures the position of diseased test scores relative to the healthy population. Compared to traditional approaches, this PV-based alternative works directly with ROC curves and is attractive when assessing covariate effects on, or incorporating <i>a priori</i> constraints of, ROC curves. Several distributions can be used to model the PV, yet little guidelines exist in the literature on which to use. Through extensive simulation studies, we investigate several parametric models for PV when data are generated from a variety of mechanisms. We discuss the pros and cons of each of these models and illustrate their applications with data from a study of prenatal ultrasound examinations and large-for-gestational age birth.</p>","PeriodicalId":37240,"journal":{"name":"Biostatistics and Epidemiology","volume":"5 2","pages":"118-133"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734584/pdf/nihms-1634812.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39915702","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Concordance Measures and Time-Dependent ROC Methods. 一致性测量和时间相关 ROC 方法。
Q3 Medicine Pub Date : 2021-01-01 Epub Date: 2021-05-25 DOI: 10.1080/24709360.2021.1926189
Norberto Pantoja-Galicia, Olivia I Okereke, Deborah Blacker, Rebecca A Betensky

The receiver operating characteristic (ROC) curve displays sensitivity versus 1-specificity over a set of thresholds. The area under the ROC curve (AUC) is a global scalar summary of this curve. In the context of time-dependent ROC methods, we are interested in global scalar measures that summarize sequences of time-dependent AUCs over time. The concordance probability is a candidate for such purposes. The concordance probability can provide a global assessment of the discrimination ability of a test for an event that occurs at random times and may be right censored. If the test adequately differentiates between subjects who survive longer times and those who survive shorter times, this will assist clinical decisions. In this context the concordance probability may support assessment of precision medicine tools based on prognostic biomarkers models for overall survival. Definitions of time-dependent sensitivity and specificity are reviewed. Some connections between such definitions and concordance measures are also reviewed and we establish new connections via new measures of global concordance. We explore the relationship between such measures and their corresponding time-dependent AUC. To illustrate these concepts, an application in the context of Alzheimer's disease is presented.

接收者操作特征曲线(ROC)显示一组阈值的灵敏度与特异性的关系。ROC 曲线下面积(AUC)是该曲线的全局标量总结。对于随时间变化的 ROC 方法,我们感兴趣的是能总结随时间变化的 AUC 序列的全局标量指标。一致性概率就是这样一个候选指标。一致性概率可以全面评估测试对随机发生且可能是右删失的事件的区分能力。如果测试能充分区分存活时间较长的受试者和存活时间较短的受试者,这将有助于临床决策。在这种情况下,一致性概率可支持对基于预后生物标志物模型的精准医疗工具进行评估,以确定总生存期。本文回顾了与时间相关的敏感性和特异性的定义。我们还回顾了此类定义与一致性测量之间的一些联系,并通过全局一致性的新测量方法建立了新的联系。我们还探讨了这些指标与其相应的随时间变化的 AUC 之间的关系。为了说明这些概念,我们介绍了在阿尔茨海默病中的应用。
{"title":"Concordance Measures and Time-Dependent ROC Methods.","authors":"Norberto Pantoja-Galicia, Olivia I Okereke, Deborah Blacker, Rebecca A Betensky","doi":"10.1080/24709360.2021.1926189","DOIUrl":"10.1080/24709360.2021.1926189","url":null,"abstract":"<p><p>The receiver operating characteristic (ROC) curve displays sensitivity versus 1-specificity over a set of thresholds. The area under the ROC curve (AUC) is a global scalar summary of this curve. In the context of time-dependent ROC methods, we are interested in global scalar measures that summarize sequences of time-dependent AUCs over time. The concordance probability is a candidate for such purposes. The concordance probability can provide a global assessment of the discrimination ability of a test for an event that occurs at random times and may be right censored. If the test adequately differentiates between subjects who survive longer times and those who survive shorter times, this will assist clinical decisions. In this context the concordance probability may support assessment of precision medicine tools based on prognostic biomarkers models for overall survival. Definitions of time-dependent sensitivity and specificity are reviewed. Some connections between such definitions and concordance measures are also reviewed and we establish new connections via new measures of global concordance. We explore the relationship between such measures and their corresponding time-dependent AUC. To illustrate these concepts, an application in the context of Alzheimer's disease is presented.</p>","PeriodicalId":37240,"journal":{"name":"Biostatistics and Epidemiology","volume":" ","pages":"232-249"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523576/pdf/nihms-1701256.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40389965","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Moving from two- to multi-way interactions among binary risk factors on the additive scale. 在可加性尺度上,二元危险因素之间从双向相互作用转向双向相互作用。
Q3 Medicine Pub Date : 2020-12-03 DOI: 10.1080/24709360.2020.1850171
Michail Katsoulis, Manuel Gomes, Christina Bamia

Many studies have focused on investigating deviations from additive interaction of two dichotomous risk factors on a binary outcome. There is, however, a gap in the literature with respect to interactions on the additive scale of >2 risk factors. In this paper, we present an approach for examining deviations from additive interaction among three or more binary exposures. The relative excess risk due to interaction (RERI) is used as measure of additive interaction. First, we concentrate on three risk factors - we propose to decompose the total RERI to: the RERI owned to the joint presence of all three risk factors and the RERI of any two risk factors, given that the third is absent. We then extend this approach, to >3 binary risk factors. For illustration, we use a sample from data from the Greek EPIC cohort and we investigate the association with overall mortality of Mediterranean diet, body mass index , and smoking. Our formulae enable better interpretability of any evidence for deviations from additivity owned to more than two risk factors and provide simple ways of communicating such results from a public health perspective by attributing any excess relative risk to specific combinations of these factors. Abbreviations: BMI: Body Mass Index; ERR: excess relative risk; EPIC: European Prospective Investigation into Cancer and nutrition; MD: Mediterranean diet; RERI: relative excess risk due to interaction; RR: relative risk; TotRERI: total relative excess risk due to interaction.

许多研究都集中在调查两个二元危险因素对二元结果的加性相互作用的偏差。然而,在bbbb2风险因素的加性尺度上的相互作用方面,文献中存在空白。在本文中,我们提出了一种方法来检查从三个或更多的二元暴露之间的加性相互作用的偏差。相互作用的相对超额风险(rei)被用来衡量加性相互作用。首先,我们关注三个风险因素——我们建议将总RERI分解为:所有三个风险因素共同存在的RERI和任意两个风险因素的RERI,假设第三个风险因素不存在。然后我们将这种方法扩展到bb30个二元风险因素。为了说明这一点,我们使用了来自希腊EPIC队列的数据样本,我们调查了地中海饮食、体重指数和吸烟与总死亡率的关系。我们的公式能够更好地解释与两个以上风险因素有关的可加性偏差的任何证据,并提供从公共卫生角度传达此类结果的简单方法,将任何超额相对风险归因于这些因素的特定组合。缩写:BMI:身体质量指数;ERR:过度的相对风险;EPIC:欧洲癌症与营养的前瞻性调查;MD:地中海饮食;rei:相互作用导致的相对超额风险;RR:相对风险;TotRERI:由于相互作用而产生的总相对超额风险。
{"title":"Moving from two- to multi-way interactions among binary risk factors on the additive scale.","authors":"Michail Katsoulis, Manuel Gomes, Christina Bamia","doi":"10.1080/24709360.2020.1850171","DOIUrl":"10.1080/24709360.2020.1850171","url":null,"abstract":"<p><p>Many studies have focused on investigating deviations from additive interaction of two dichotomous risk factors on a binary outcome. There is, however, a gap in the literature with respect to interactions on the additive scale of >2 risk factors. In this paper, we present an approach for examining deviations from additive interaction among three or more binary exposures. The relative excess risk due to interaction (RERI) is used as measure of additive interaction. First, we concentrate on three risk factors - we propose to decompose the total RERI to: the RERI owned to the joint presence of all three risk factors and the RERI of any two risk factors, given that the third is absent. We then extend this approach, to >3 binary risk factors. For illustration, we use a sample from data from the Greek EPIC cohort and we investigate the association with overall mortality of Mediterranean diet, body mass index , and smoking. Our formulae enable better interpretability of any evidence for deviations from additivity owned to more than two risk factors and provide simple ways of communicating such results from a public health perspective by attributing any excess relative risk to specific combinations of these factors. <b>Abbreviations:</b> BMI: Body Mass Index; ERR: excess relative risk; EPIC: European Prospective Investigation into Cancer and nutrition; MD: Mediterranean diet; RERI: relative excess risk due to interaction; RR: relative risk; TotRERI: total relative excess risk due to interaction.</p>","PeriodicalId":37240,"journal":{"name":"Biostatistics and Epidemiology","volume":"4 1","pages":"282-293"},"PeriodicalIF":0.0,"publicationDate":"2020-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8098792/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38930293","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Biostatistics and Epidemiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1